MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2
出版年份 2016 全文链接
标题
MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2
作者
关键词
microRNA-26a (miR-26a), Hepatocellular carcinoma (HCC), Enhancer of zeste homolog 2 (EZH2), Epithelial-mesenchymal transition (EMT)
出版物
Journal of Hematology & Oncology
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-01-06
DOI
10.1186/s13045-015-0229-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma
- (2015) Zong-Tao Chai et al. Journal of Hematology & Oncology
- miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation
- (2015) Zhi-Jian Zou et al. Oncotarget
- The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma
- (2014) Shu-Bin Gao et al. JOURNAL OF HEPATOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Long Noncoding RNA-EBIC Promotes Tumor Cell Invasion by Binding to EZH2 and Repressing E-Cadherin in Cervical Cancer
- (2014) Ning-xia Sun et al. PLoS One
- Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling
- (2014) Ning Zhang et al. PLoS One
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway
- (2013) Xin Yang et al. HEPATOLOGY
- MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway
- (2013) Xin Yang et al. HEPATOLOGY
- MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma
- (2013) Zong-Tao Chai et al. PLoS One
- Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
- (2012) N. P. A. Devika Gunasinghe et al. CANCER AND METASTASIS REVIEWS
- EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
- (2012) Ester Sánchez-Tilló et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating β-catenin
- (2012) Jinqiang Zhang et al. GASTROENTEROLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
- (2011) M. P. H. M. Jansen et al. BREAST CANCER RESEARCH AND TREATMENT
- MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
- (2011) J. Lu et al. CANCER RESEARCH
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- (2011) Masashi Takawa et al. CANCER SCIENCE
- Deregulated expression of miR-26a and Ezh2 in Rhabdomyosarcoma
- (2011) Roberta Ciarapica et al. CELL CYCLE
- Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma
- (2011) Cheng Wang et al. MOLECULAR CARCINOGENESIS
- The emerging role of miR-200 family of MicroRNAs in epithelial-mesenchymal transition and cancer metastasis
- (2011) Manav Korpal et al. RNA Biology
- Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101 and miR-98
- (2011) N M Alajez et al. Cell Death & Disease
- Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer
- (2010) B. Zhang et al. CARCINOGENESIS
- Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer
- (2010) Chad J. Creighton et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- Epithelial–mesenchymal transition in hepatocellular carcinoma
- (2009) Franziska van Zijl et al. Future Oncology
- The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
- (2009) J. T. Huse et al. GENES & DEVELOPMENT
- Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Donald Poon et al. LANCET ONCOLOGY
- MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
- (2009) Junfang Ji et al. NEW ENGLAND JOURNAL OF MEDICINE
- E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas
- (2008) Alan Wells et al. CLINICAL & EXPERIMENTAL METASTASIS
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now